PHIO PHARMACEUTICALS CORP's ticker is PHIO and the CUSIP is 71880W303. A total of 15 filers reported holding PHIO PHARMACEUTICALS CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | – | 10 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 40,684 | $83,000 | 0.01% |
| Virtu Financial LLC | 45,458 | $92,000 | 0.01% |
| Total Clarity Wealth Management, Inc. | 1,500 | $3,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 153,100 | $311,000 | 0.00% |
| Cetera Investment Advisers | 30,000 | $61,000 | 0.00% |
| UBS Group AG | 6,241 | $13,000 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 42,137 | $86,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 63 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 53 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |